Wound Dressing For Negative Pressure Wound Therapy Articles & Analysis
5 news found
Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The NPSIMS utilizes an innovative mode-of-action that eliminates the expensive electromechanical pump, battery, and electronics found in most other negative pressure wound ...
Medovate is delighted to be joining the Association of British HealthTech Industries (ABHI) US Accelerator 2022 cohort. The dynamic Cambridge-based development company, who are helping to bring to life pioneering medical devices, is participating in the programme for a second year running. Now in its fifth year, the ABHI US Accelerator, conducted in partnership with the Dell Medical School in ...
ByMedovate
” An interim analysis after recruitment of the first 5 participants following elective plastic surgical procedures has showed that all patients were discharged with a single NPSIMS™ device that maintained negative pressure and managed wound exudate for a total of 7 days. Follow up was for 30 days. ...
Aatru Medical, LLC ("Aatru") announced today that its technical Abstract has been accepted for presentation at both the SAWC/WHS 2020 conference in North Carolina and also at EWMA 2020, to be held in London, England. The 2020 Symposium on Advanced Wound Care (SAWC)/Wound Healing Society (WHS) meeting is the largest gathering of wound care ...
Aatru Medical, LLC ("Aatru") is pleased to announce its recent submission to the FDA of a traditional 510(k) premarket notification application for the company's first product, NPSIMS - Negative Pressure Surgical Incision Management System. The submission efforts were led by Aatru President and Board Member Edward Armstrong, in conjunction with Coastal Consulting Group, NAMSA, and DuVal & ...
